IP Library › Granted Patent US 11,123,366
Granted Patent B1
US 11,123,366 · App. 14/969,110 · Granted Sep 21, 2021

Methods, materials, and systems for treating injuries to the central nervous system using light emitting nanoparticles

Inventors: Sharief Taraman (Laguna Niguel, CA); Spyro Mousses (Scottsdale, AZ)
Assignee: Children's Hospital of Orange County
A61K33/24A61K41/0057A61N5/0601A61N5/0616A61N2005/0659B82Y5/00Y10S977/915
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,366
App. No.
14/969,110
Granted
Sep 21, 2021
Kind
B1
Abstract

The present invention relates to the use of light-emitting, water soluble nanoparticles in the treatment of disorders of the central nervous system.

Claims (13)

1. A method for treating a disorder of the central nervous system in a subject suffering from a central nervous system injury, such method comprising:

a) activating synthetic, light-emitting, water soluble nanoparticles to create activated light-emitting nanoparticles; and

b) administering to said subject a composition comprising said activated light-emitting nanoparticles;

wherein the activated light-emitting nanoparticles emit light in the infra-red or near infra-red spectrum.

2. The method of claim 1 , where the disorder of the central nervous system is the result of an ischemic stroke.

3. The method of claim 1 , wherein the disorder of the central nervous system is the result of an impact to the head.

4. The method of claim 1 , wherein the nanoparticles are selected from the group consisting of quantum dots, silica nanoparticles, magnetic iron oxide “nanoworms,” Cr3+/Pr3+ co-doped zinc gallogermanate, and gold nanoparticles.

5. A method for treating or preventing oxidative damage to mitochondria following reperfusion in a subject suffering from a central nervous system injury, such method comprising administering to said subject a composition comprising activated synthetic, light-emitting, water-soluble nanoparticles,

wherein, synthetic, light-emitting, water-soluble nanoparticles are activated prior to administration to create said activated synthetic, light-emitting, water-soluble nanoparticles; and

wherein said activated synthetic, light-emitting, water-soluble nanoparticles emit light in the infra-red or near infra-red spectrum.

6. The method of claim 5 , where the disorder of the central nervous system is the result of an ischemic stroke.

7. The method of claim 5 , wherein the disorder of the central nervous system is the result of an impact to the head.

8. The method of claim 5 , wherein the nanoparticles are selected from the group consisting of quantum dots, silica nanoparticles, magnetic iron oxide “nanoworms,” Cr3+/Pr3+ co-doped zinc gallogermanate, and gold nanoparticles.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2021
From: TARAMAN, SHARIEF; MOUSSES, SPYRO
To: CHILDREN'S HOSPITAL OF ORANGE COUNTY
Reel/Frame 057249/0864 →
Continuity (2)
Provisional Application 62091677 · Dec 15, 2014
Provisional Application 62159960 · May 12, 2015
Cited By (2)
US 12,285,182 US 12,564,728